The Sugar Beat
- GLP-1 Receptor Agonists at EASD 2020: Poster Pearls
- New Diabetes Guidelines: 'Treat to Mitigate'
- Once-Weekly 'Centennial Insulin': Will It Live Up to the Promise?
- Obesity and the Bitter Pill of Truth
- CGM in Type 2 Diabetes: Invaluable or Too Expensive?
- VERTIS-CV Results 'Disappoint,' Raise More Questions
- Is COVID-19 Fueling the Fire of Opinion-Based Medicine?
- The Links Between COVID-19 and Diabetes, Known and Unknown
- Cardios, Nephros, PCPs -- We're All Diabetologists Now
- Top 5 Diabetes Highlights From 2019
- Recreational Marijuana in Diabetes: Not All Fun and Games
- 'Poised on a Paradigm Shift': The REWIND and DECLARE Trials
- CREDENCE Takes SGLT2 Inhibitors 'to the Next Level'
- Fielding the Dangers of Fasting and Feasting With Diabetes
- Diabetes 360: A Plan to Quell the 'Tsunami' of Diabetes
- Generic DPP-4 Inhibitors Would Be a 'Shot in the Arm'
- The Artificial Pancreas Has Arrived in Canada: What to Expect
- Surviving the Holidays With Diabetes
- Dispelling the Myths About Obesity
- SGLT2 Inhibitors: Unreal Primary Prevention?